1 results match your criteria: "Medical University Vienna and Pancreatic Cancer Unit[Affiliation]"
Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection.
J Gastrointest Surg
March 2020
Department of Surgery, Comprehensive Cancer Center (CCC), Medical University Vienna and Pancreatic Cancer Unit, Spitalgasse 23, 1090, Vienna, Austria.
Background: The systemic immune-inflammation index based on peripheral neutrophil, lymphocyte, and platelet counts has shown a prognostic impact in several malignancies. The aim of this study was to determine the prognostic role of systemic immune-inflammation index in patients with pancreatic ductal adenocarcinoma undergoing resection.
Methods: Consecutive patients who underwent surgical resection at the department of surgery at the Medical University of Vienna between 1995 and 2014 were included into this study.